Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_provenance.
- NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_assertion wasGeneratedBy ECO_0000203 NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_provenance.
- NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_assertion wasDerivedFrom befree-20150227 NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_provenance.
- NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_assertion SIO_000772 25671252 NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_provenance.
- NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_assertion evidence source_evidence_literature NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_provenance.
- NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_assertion description "[The order in which JAK2 and TET2 mutations were acquired influenced clinical features, the response to targeted therapy, the biology of stem and progenitor cells, and clonal evolution in patients with myeloproliferative neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914060.RA4Axvva5lKIrP5GwhH4W1VCqk6Z6k13zwoF0j7i2xLG4130_provenance.